NS · Pharmaceuticals
Pharmaceuticals & Biotechnology
Solara Active Pharma Sciences Ltd (SOLARA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-03, reported market cap is $27.77B, P/E ratio is -384.33, net margin is -14.8%, dividend yield is 0.52%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Solara Active Pharma Sciences Ltd (SOLARA) has a reported market cap of $27.77B (data as of 2026-07-03).
The price-to-earnings (P/E) ratio for Solara Active Pharma Sciences Ltd (SOLARA) is -384.33 (data as of 2026-07-03).
Solara Active Pharma Sciences Ltd (SOLARA) shows a reported dividend yield of 0.52%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-03).
Solara Active Pharma Sciences Ltd (SOLARA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
SOLARA is listed on NS.
Solara Active Pharma Sciences Ltd (SOLARA) reports a net margin of -14.8% (data as of 2026-07-03).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.